NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
157 hedge funds and large institutions have $1.22B invested in NEVRO CORP. in 2018 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 56 increasing their positions, 40 reducing their positions, and 46 closing their positions.
75% more call options, than puts
Call options by funds: $32.7M | Put options by funds: $18.7M
40% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 40
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 171 → 157 (-14)
28% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 46
32% less capital invested
Capital invested by funds: $1.81B → $1.22B (-$589M)
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$40.5M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$33.6M |
| 3 |
BC
Broadfin Capital
New York
|
+$33.1M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$32.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$31M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$82.4M |
| 2 |
O
OrbiMed
New York
|
-$77.4M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$70.8M |
| 4 |
Jennison Associates
New York
|
-$48.9M |
| 5 |
ZCI
Zevenbergen Capital Investments
Edmonds,
Washington
|
-$38.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
201
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$1K | -15 | Closed |
|
|
LFG
202
Larson Financial Group
St Louis,
Missouri
| – | +$533 | +12 | New |
|
NVRO Hedge Fund Activity: Q4 2018 in Review
157 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2018, worth a combined $1.22B — down 32% from $1.81B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of NVRO and 33 opened new positions — a net loss of 13 holders — while 40 trimmed existing stakes and 56 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $40.5M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $82.4M sold.
- 157 institutional investors held NEVRO CORP. (NVRO) as of Q4 2018, down from 171 in Q3 2018.
- Funds reported $1.22B of NEVRO CORP. stock for Q4 2018, down 32% quarter-over-quarter.
- 33 funds opened new NEVRO CORP. positions in Q4 2018 and 46 closed out, a net change of -13 holders.
- The largest NEVRO CORP. buyer in Q4 2018 was D.E. Shaw & Co, an estimated $40.5M added.
- The largest NEVRO CORP. seller in Q4 2018 was Consonance Capital Management, an estimated $82.4M sold.
Based on aggregated 13F filings for Q4 2018.